试析He-Ne激光沿经络自动照射仪的应用

本文介绍He-Ne激光沿经络自动照射仪的结构、特点,分析了激光与组织相互作用的物理效应和生物效应,提出了该仪器在针灸临床中的应用。     

金莲花软胶囊中总黄酮的含量测定

目的建立紫外法测定金莲花软胶囊中总黄酮的含量测定方法。方法采用紫外分光光度计,检测波长500nm,以芦丁为标准品测定本品总黄酮含量。结果测得线性回归方程为y=0.11359x-0.0034,r=0.9999(n=5),平均回收率为99.67%,RSD为0.58%(n=9)。结论本方法简便,准确、重复性好。     

Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer.

PURPOSE: Tumor necrosis treatment (TNT) uses degenerating tumor cells and necrotic regions of tumors as targets for radioimmunotherapy. Previous studies in animal tumor models and clinical trials have demonstrated that when linked to the therapeutic radionuclide iodine-131, recombinant chimeric TNT antibody ((131)I-chTNT) can deliver therapeutic doses to tumors regardless of the location or type of malignancy. Therapeutic efficacy and toxicity of (131)I-chTNT in advanced lung cancer patients were studied in this pivotal registration trial. PATIENTS AND METHODS: Patients with advanced lung cancer were treated with systemic or intratumoral injection of (131)I-chTNT in eight oncology centers in China. The objective response rate (ORR) was assessed as the primary end point. RESULTS: All 107 patients who were entered onto the study and completed therapy had experienced treatment failure after prior radiotherapy or chemotherapy a mean of three times. The results showed an ORR of 34.6% (complete response, 3.7%; partial response, 30.8%; no change, 55.1%; and progressive disease, 10.3%) in all patients and 33% in 97 non-small-cell lung cancer patients. A biodistribution study demonstrated excellent localization of the radioactivity in tumors in both systemically and intratumorally injected patients. The most obvious adverse side effect was mild and reversible bone marrow suppression. CONCLUSION: Radioimmunotherapy with (131)I-chTNT was well tolerated and can be used systemically or locally to treat refractory tumors of the lung.     

Malignant transformation of nevus sebaceous to basal-cell carcinoma: Case series,literature review,and management algorithm

Nevus sebaceous (NS) is a common congenital hamartoma of the skin composed predominantly of sebaceous glands. Although most NS are benign skin tumors, malignant transformations have been reported. There is still controversy about the lifetime risk of malignant degeneration and precise surgical criteria. This study reports cases of malignant degeneration and suggests a surgical treatment algorithm. The medical records of patients with basal-cell carcinoma (BCC) arising from NS between January 2001 and January 2021 were retrospectively reviewed. Patient demographics including lesion location, and tumor size were investigated. The symptoms, histological findings before and after excision, complications, and recurrence during 2-year follow-up periods were investigated. Ten patients were identified with BCC arising from NS lesions. All patients were female and the mean age was 52.11 years. All patients complained of sudden morphological changes, the most common type being rapid color changes. Two cases had histological findings that showed a miss-match between punch biopsy and excisional biopsy results. No recurrence was detected 2 years after surgeries in any patients. Cases after third stage, especially in over 40 years who report morphologic changes, should undergo total surgical excision as the first approach, with strong suspicion of malignant degeneration.     

Washable and stretchable fiber with heat and ultraviolet color conversion

Wearable fabric-type color conversion sensors are very effective in quickly expressing danger or warnings to people. In particular, they can visually show information regarding the external environment, such as its temperature or ultraviolet (UV) intensity. However, a wearable sensor worn on the human body should maintain its sensing performance without deterioration even when exposed to various external stimuli, such as the repeated movements caused by human activity, sweat, and washing. In this study, thermochromic and UV photochromic fibers were fabricated to maintain stable color conversion functionality in response to temperature and UV irradiation even after continuous tensile-shrinkage, exposure to sweat and detergent solution. The thermochromic or UV photochromic materials were coated on the inside and outside of strands constituting a highly elastic spandex fiber. By adding polydimethylsiloxane to the color-changing material, the physical and chemical stability of the color-conversion thin film coated on the strand increased. The fabricated thermochromic fiber had a blue-green color and changed to white as the temperature increased, whereas the fabricated UV photochromic fiber was white and changed to purple as the UV intensity increased. In addition, the color conversion coating film was not lost even when exposed to repeated stretching and sweat/washing solutions, and a stable color-change reactivity was maintained. The thermochromic and UV photochromic fibers introduced in this study are expected to contribute to the commercialization of wearable colorimetric sensors by solving the problems regarding the physical stimulation and washing stability of existing coating-type color conversion fibers and textiles.

Thermochromic- and UV-photochromic-materials embedded stretchable fibers showed stable color conversion functionality in response to temperature and UV irradiation even after continuous tensile-shrinkage, exposure to sweat, and detergent exposure.     

儿童特发性再生障碍性贫血的诊断与治疗

再生障碍性贫血(再障)以全血细胞减少和骨髓增生降低为显著特点。绝大多数病例为特发性,部分为继发性,与辐射、化学物和药物暴露、病毒感染有关。特发性再障发病机制不清,但免疫机制介导的造血干细胞损伤发挥着极为重要的作用。诊断主要依靠典型的临床表现和骨髓形态学检查,注意与其他可导致全血细胞减少的疾病鉴别,尤其是低增生性骨髓增生异常综合征。应综合患者年龄、临床严重程度、有无造血干细胞来源及其种类等因素,制定个体化治疗方案,合理选择联合免疫抑制治疗和造血干细胞移植的类型和时机。重视对症支持治疗措施。     

解毒通络方通过TGF-β1/Smad和ROCK通路对大鼠心肌纤维化的改善作用

目的:探讨解毒通络方在大鼠心肌纤维化进程中的作用,并阐明其作用机制.方法:30只SPF级Wistar大鼠随机分为正常对照组、模型组、卡托普利组、低剂量解毒通络方组和高剂量解毒通络方组(n=6),以5 mg·kg-1盐酸异丙肾上腺素皮下注射法复制大鼠心肌纤维化模型,卡托普利组、低剂量解毒通络方组和高剂量解毒通络方组大鼠分...     

Human Milk Metabolomics Are Related to Maternal Adiposity,Infant Growth Rate and Allergies: The Chinese Human Milk Project

The metabolomic profiles of Chinese human milk have been poorly documented. The objective of the study was to explore associations between human milk metabotypes, maternal adiposity, infant growth patterns, and risk of allergies. Two hundred mother–infant dyads from seven cities were randomly selected from the Chinese Human Milk Project (CHMP). Untargeted human milk metabolomic profiles were determined using HPLC-MS/MS. Two human milk metabotypes were identified using principal component analysis. Principal component (PC) 1 was characterized by high linoleic acid metabolites with low purine nucleosides and metabolites of glutamate and glutathione metabolism. PC 2 was characterized by high glycerophospholipids and sphingomyelins content. Higher PC1 scores were associated with slower infant growth rate and higher ambient temperature (p < 0.05). Higher PC 2 scores were related to higher maternal BMI and increased risk of infant allergies (p < 0.05). Future work is needed to understand the biologic mechanisms of these human milk metabotypes.     

Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3

ContextAcute lung injury (ALI) is a serious heterogenous pulmonary disorder. Fraxinol was selected for this study since it is a simple coumarin compound, not previously investigated in ALI.ObjectivesThis study investigates the ALI therapeutic effect and mechanisms of fraxinol.Materials and methodsMale BALB/c mice were treated with fraxinol (20, 40, and 80 mg/kg) following intranasal injection of lipopolysaccharide (LPS; 10 μg in 50 μL). The mice in control group were intratracheally injected with 50 μL phosphate buffered saline (PBS). Raw264.7 cells were treated with fraxinol by 100 ng/mL LPS for 6 h, then treated by different concentrations of fraxinol (5, 10, and 25 μM) for 48 h. Cells in control group were treated with PBS.ResultsFraxinol with doses of 20, 40, and 80 mg/kg significantly attenuated LPS-induced lung injury in mice (lung injury score, 10.4, 31.2, 50.3%). Fraxinol attenuated the apoptosis and nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing-3 (NLRP3) activation induced by LPS (apoptosis, 18.3, 30.2, 55.6%; NLRP3, 30.0, 47.7, 63.6%). The anti-apoptosis and anti-inflammation effects of fraxinol were also confirmed in Raw264.7 cells (apoptosis, 38.8, 55.3, 68.9%; NLRP3, 20.6, 55.7, 73.9%).Discussion and conclusionThe anti-ALI effects of fraxinol maybe by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas axis and inhibiting NLRP3 inflammasome. Our research provides a candidate drug in the treatment of ALI.